Enrollment in clinical trials for novel cancer drugs has reduced drastically since the start of the COVID-19 pandemic. This is due in part to a pause in recruitment on behalf of institutions to curb the spread of the virus as well as increased hesitation from patients themselves. Yourway has an extensive direct-to-patient program, eliminating the need for in-person trial visits, which aids in trial recruitment and retention.
November 20, 2020
AstraZeneca’s COVID-19 vaccine will be tested at an NYU Langone trial site in Long Island, in addition to four other sites in New York City. The NYU Langone’s Vaccine Center is seeking to enroll 1,000 participants aged 18 to 85 to enroll in the phase III large-scale clinical trial, which is sponsored by the National Institutes of Health. This trial is part of the ongoing 30,000-person trial of the vaccine being tested globally. With our headquarters in Allentown, Pennsylvania and 21 strategically located depots around the world, Yourway is well-positioned to distribute clinical trial supplies for even the most critical and extensive trials.
Patients enrolled in the Pfizer and BioNTech clinical trial for a COVID-19 vaccine who originally receive a placebo will now be given the preventative vaccine. This will not occur until the U.S. Food and Drug Administration grants the vaccine an emergency use authorization or further regulatory approval, however. Trials are generally blinded so participants do not know whether they are receiving a placebo or treatment – though Pfizer hopes to amend this pending approval from regulatory bodies. Yourway has worked throughout the coronavirus pandemic to ensure drug products are delivered on time and even directly to patients, 24/7.
November 17, 2020
President of Brazil, Jair Bolsonaro, has suspended trials of a COVID-19 vaccine trial in Brazil. The vaccine is made by Chinese company Sinovac Biotech. The trial is currently in the final stages, globally. The trial suspension was due to an undisclosed serious adverse event. With more than 20 strategically located depots worldwide, Yourway can deliver supplies seamlessly from one country and continent to another.
November 16, 2020
Clinical trial results from Pfizer and BioNTech’s COVID-19 vaccine is thus far 90% effective against coronavirus, beating previous expectations of a 60-70% effectivity rate. Pfizer is still conducting phase III trials, which could impact the overall performance of the vaccine. Yourway is the go-to premium courier for clinical trials and drug product shipments. We handle each shipment on an individual basis, consulting with our clients to determine the best courier service to meet the needs of the trial and patients.
November 12, 2020
November 10, 2020
November 9, 2020
November 3, 2020